Ph. 405-942-3040 / jack@pdrx.com
PD-Rx Pharmaceuticals and PrescriptiCare Team up
to provide cost effective pharmacy healthcare.
OKLAHOMA CITY, OK, July 20, 2000 – PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (OTC BB: PDRX) today announced the completion of an agreement that will extend the services that PDRx currently offers to physicians and Managed Care Organization (MCO) across the United States.
PDRx provides an in-house computerized pharmacy system for Point of Care services. While PrescriptiCare offers mail order and PBM services to the healthcare industry. PDRx will begin providing access to over 2500 physicians to network and electronically submit a prescription to PresciptiCare for pharmaceutical claims adjudication and mail order services.
With the use of PDRx proprietary software system, “PDRx -Net”, an electronic prescription can be forwarded directly to PrescriptiCare to be filled as a mail order prescription or even utilize their PBM services to verify patient eligibility and fill the prescription at the point of care. PDRx has also completed the development of a Handheld PC wireless electronic prescribing device called “RxWebPad” utilizing the popular Windows™ CE operating system. It allows electronic prescribing, routing of prescription information and capturing of prescription data at the point of care. Our goal is to develop a matrix of cost containment tools and e-connectivity that MCO’s can utilize in their networks throughout the healthcare industry.
PDRx currently offer products in five categories: point of care electronic medication triage, Internet services, patient education products, medical/surgical supplies and prepackaged medication. Our PDRx-Net System is a software/hardware communication network that provides physicians the capabilities to interact and network with traditional and non-traditional pharmacy delivery systems. We also sell our prepackaged medications to physicians so they can offer their patients the convenience and confidentiality of receiving prescription medications in the privacy of the physician’s office.
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry.